Robert Coffin
Oprichter bij REPLIMUNE GROUP, INC.
Vermogen: 16 M $ op 30-06-2024
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Philip Astley-Sparke | M | 51 |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | 9 jaar |
| Sushil Patel | M | 52 | 3 jaar | |
| Dieter Weinand | M | 63 | 6 jaar | |
| Paolo Pucci | M | 63 | 4 jaar | |
| Joseph Slattery | M | 59 | 7 jaar | |
| Hyam Levitsky | M | 66 | 6 jaar | |
| Tyler Jacks | M | 63 | 12 jaar | |
| Eric Morgan Yeatman | M | 61 |
Imperial College London
| 38 jaar |
| Kapil Dhingra | M | 64 | 7 jaar | |
| Christy Oliger | F | 54 | 3 jaar | |
| Andrew Schwendenman | M | 47 | 4 jaar | |
| Veleka Peeples-Dyer | F | 52 | 1 jaar | |
| Emily Hill | F | 44 | 1 jaar | |
| Arleen Goldenberg | F | - | - | |
| Konstantinos Xynos | M | 57 | 2 jaar | |
| Christopher Sarchi | M | 55 | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Stephen A. Gorgol | M | 65 |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | 6 jaar |
| Jean Franchi | F | 57 | 4 jaar | |
| Colin Love | M | 65 |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | 23 jaar |
| Kevin Sharer | M | 76 | 20 jaar | |
| David W. Beier | M | 75 | 10 jaar | |
| Hugo Slootweg | M | 53 |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | 17 jaar |
| Pamela Esposito | M | 50 |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | 11 jaar |
| George Morrow | M | 72 | 10 jaar | |
| Kamtorn Sila-on | M | 54 |
Imperial College London
| 4 jaar |
| Yon-Ho Chong | M | - |
Imperial College London
| 9 jaar |
| Howard Goldsweig | M | - |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA.
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | 5 jaar |
| James Daly | M | 62 | 9 jaar | |
| David McShane | M | - |
Imperial College London
| 7 jaar |
| Anne Marie Woodland | F | - |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | 10 jaar |
| Wendy Aritenang Yazid | M | 69 |
Imperial College London
| 4 jaar |
| Raymond C. Jordan | M | 70 | 7 jaar | |
| Marco Renoldi | M | 67 | 3 jaar | |
| Annette L. Such | F | 55 | - | |
| Laurie Stelzer | F | 56 | 2 jaar | |
| Mohammad Amin Liew bin Abdullah | M | 61 |
Imperial College London
| 7 jaar |
| Alan McLean | M | - |
Imperial College London
| 6 jaar |
| Jason Rhodes | M | 54 | 7 jaar | |
| David S. Latchman | M | - |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA.
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | - |
| Anna Richo | F | 63 | 9 jaar | |
| Otello Stampacchia | M | 55 | 7 jaar | |
| Frederick Gluck | M | 88 | 13 jaar | |
| Tanya Lewis | F | 53 | 4 jaar | |
| Aaqib Mirza | M | - |
Imperial College London
| 4 jaar |
| Niaz Haider | M | - |
Imperial College London
| 3 jaar |
| Chuan Poh Lim | M | 70 |
Imperial College London
| 1 jaar |
| João Afonso Ramalho Sopas Pereira Bento | M | 63 |
Imperial College London
| 3 jaar |
| Karl Alomar | M | - |
Imperial College London
| 3 jaar |
| Michael Shipman | M | - |
Imperial College London
| 3 jaar |
| Paul Skipworth | M | 56 |
Imperial College London
| 4 jaar |
| Samuel Paul Oliver Carew-Jones | M | 49 |
Imperial College London
| 4 jaar |
| Ihsan Jawad | M | - |
Imperial College London
| 4 jaar |
| Ravinder Dhaliwal | M | - |
Imperial College London
| 3 jaar |
| Ian C. Lennon | M | - |
Imperial College London
| 3 jaar |
| D'Souza Kevin | M | - |
Imperial College London
| 4 jaar |
| David Syriani | M | - |
Imperial College London
| 4 jaar |
| Sotirios Hadjimichael | M | 64 |
Imperial College London
| 3 jaar |
| Imoni L. Akpofure | F | - |
Imperial College London
| 4 jaar |
| Justin Leung | M | 56 |
Imperial College London
| 4 jaar |
| Sam Rahman | M | - |
Imperial College London
| 1 jaar |
| Robin Hargrove | M | 58 |
Imperial College London
| 4 jaar |
| Alain Michaelis | M | 57 |
Imperial College London
| 4 jaar |
| Agus Hasan Reksoprodjo | M | 61 |
Imperial College London
| 3 jaar |
| Alexandre Quirici | M | - |
Imperial College London
| 3 jaar |
| Natasha Foong | F | - |
Imperial College London
| 1 jaar |
| Sharifuddin Bin Md. Zaini Al-manaf | M | 54 |
Imperial College London
| 4 jaar |
| Paul Dentskevich | M | - |
Imperial College London
| 4 jaar |
| Hironori Higashide | M | - |
Imperial College London
| 2 jaar |
| Cheong Thard Hoong | M | 55 |
Imperial College London
| 4 jaar |
| Patrick Chidley | M | - |
Imperial College London
| 3 jaar |
| Pallonji Mistry | M | 56 |
Imperial College London
| 4 jaar |
| Thomas Michael Hughes | M | 56 |
Imperial College London
| 4 jaar |
| Iain Lindsay | M | - |
Imperial College London
| 4 jaar |
| Brahmal Vasudevan | M | 55 |
Imperial College London
| 3 jaar |
| Eli Katz | M | - |
Imperial College London
| 4 jaar |
| Nigel Laurie Lee | M | 57 |
Imperial College London
| 1 jaar |
| Kee Way Lim | M | 58 |
Imperial College London
| 1 jaar |
| Bernard Factor | M | - |
Imperial College London
| 4 jaar |
| Wai Keung Yuen | M | 60 |
Imperial College London
| 4 jaar |
| Robert Taylor | M | - |
Imperial College London
| 4 jaar |
| Tudor Thomas | M | - |
Imperial College London
| 4 jaar |
| Angus S. J. Fraser | M | - |
Imperial College London
| 5 jaar |
| Helen Alexander | F | 62 |
Imperial College London
| 4 jaar |
| John Coleman O'Donohue | M | 60 |
Imperial College London
| 2 jaar |
| Mahendra Deonarain | M | - |
Imperial College London
| 4 jaar |
| Siew Ge Ng | M | 68 |
Imperial College London
| 1 jaar |
| Andrew Sean Holmes | M | 60 |
Imperial College London
| 3 jaar |
| Andrew Creeke | M | - |
Imperial College London
| 3 jaar |
| Sarah A. Hedger | F | 52 |
Imperial College London
| 1 jaar |
| Philippe M. R. Guinot | M | - |
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | 8 jaar |
| Alexander Fortescue | M | 56 |
Imperial College London
| 3 jaar |
| Chi Ho Wong | M | - |
Imperial College London
| 4 jaar |
| Hua Shan Wang | M | 62 |
Imperial College London
| 3 jaar |
| Noel C. Machingawuta | M | - |
Imperial College London
| 3 jaar |
| Jean-Marc Pierre Gales | M | 61 |
Imperial College London
| 4 jaar |
| Jonathan Faiman | M | 55 |
Imperial College London
| 4 jaar |
| Steve Whelan | M | - |
Imperial College London
| 4 jaar |
| Erik Urnes | M | 53 |
Imperial College London
| 3 jaar |
| Tony Day | M | - |
Imperial College London
| 4 jaar |
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigd Koninkrijk | 65 | 65.66% |
| Verenigde Staten | 36 | 36.36% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Robert Coffin
- Persoonlijk netwerk
